SPOTLIGHT -
Slideshow
Author(s):
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care
Treating ‘Morally Objectionable’ Patients
Diagnostic Considerations in Clinical Cognitive Assessment
What Will the Future of Alzheimer Disease Treatment Look Like?
Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia